Clinical Trial Update: A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops [Phase 3]

View source ↗

Summary

Phase III clinical trial update evaluating two low-concentration atropine sulfate eye drops for myopia. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine sulfate eye drop (low concentration) - Product 1 (atropine sulfate eye drop, low concentration)
• Atropine sulfate eye drop (low concentration) - Product 2 (atropine sulfate eye drop, low concentration)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Myopia | Phase 3 | Status: ACTIVE_NOT_RECRUITING